Stocks and Investing
Stocks and Investing
Tue, June 8, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, June 7, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Geoffrey Porges Maintained (AMGN) at Hold with Increased Target to $238 on, Jun 7th, 2021
Geoffrey Porges of SVB Leerink, Maintained "Amgen Inc." (AMGN) at Hold with Increased Target from $230 to $238 on, Jun 7th, 2021.
Geoffrey has made no other calls on AMGN in the last 4 months.
There are 5 other peers that have a rating on AMGN. Out of the 5 peers that are also analyzing AMGN, 2 agree with Geoffrey's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Kennen MacKay of "RBC Capital" Maintained at Hold with Decreased Target to $217 on, Wednesday, April 28th, 2021
- Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $230 on, Friday, March 5th, 2021
These are the ratings of the 3 analyists that currently disagree with Geoffrey
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $278 on, Wednesday, April 28th, 2021
- Steve Chesney of "Atlantic Equities" Downgraded from Hold to Sell and Held Target at $200 on, Wednesday, April 28th, 2021
- Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $259 on, Wednesday, April 28th, 2021
Contributing Sources